Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	EWSR1 TAF15 ARID1B SS18L1 FUS ZMIZ1	7.02e-07	562	13	6	GO:0003712
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	TAF15 FUS ILF3 HNRNPA3	2.31e-05	276	13	4	GO:0003730
GeneOntologyMolecularFunction	transcription coactivator activity	ARID1B SS18L1 FUS ZMIZ1	3.34e-05	303	13	4	GO:0003713
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	EWSR1 TAF15 ARID1B SS18L1 FUS ZMIZ1	4.57e-05	1160	13	6	GO:0030674
GeneOntologyMolecularFunction	molecular adaptor activity	EWSR1 TAF15 ARID1B SS18L1 FUS ZMIZ1	1.10e-04	1356	13	6	GO:0060090
GeneOntologyMolecularFunction	mRNA binding	TAF15 FUS ILF3 HNRNPA3	8.05e-04	694	13	4	GO:0003729
GeneOntologyMolecularFunction	single-stranded RNA binding	HNRNPDL ILF3	2.29e-03	111	13	2	GO:0003727
GeneOntologyCellularComponent	nBAF complex	ARID1B SS18L1	4.26e-05	16	13	2	GO:0071565
GeneOntologyCellularComponent	SWI/SNF superfamily-type complex	ARID1B SS18L1	1.58e-03	96	13	2	GO:0070603
HumanPheno	Proximal amyotrophy	HNRNPDL TFG FUS	4.75e-05	58	7	3	HP:0007126
HumanPheno	Motor neuron atrophy	TFG TAF15 FUS	7.01e-05	66	7	3	HP:0007373
HumanPheno	Muscle fibrillation	TFG TAF15 FUS	2.22e-04	97	7	3	HP:0010546
HumanPheno	Cachexia	EWSR1 TAF15 FUS	2.43e-04	100	7	3	HP:0004326
HumanPheno	Abnormality of the musculature of the lower limbs	HNRNPDL TFG TAF15 FUS	3.45e-04	297	7	4	HP:0001437
HumanPheno	Fatigable weakness	TFG TAF15 FUS	4.27e-04	121	7	3	HP:0003473
HumanPheno	Abnormal synaptic transmission at the neuromuscular junction	TFG TAF15 FUS	4.37e-04	122	7	3	HP:0003398
HumanPheno	Abnormal peripheral nervous system synaptic transmission	TFG TAF15 FUS	4.37e-04	122	7	3	HP:0030191
HumanPheno	Abnormal synaptic transmission	TFG TAF15 FUS	4.37e-04	122	7	3	HP:0012535
MousePheno	perinatal lethality	MEX3B ARID1B AMOTL1 FUS ILF3 HNRNPA3	4.35e-05	1130	10	6	MP:0002081
MousePheno	perinatal lethality, complete penetrance	ARID1B AMOTL1 FUS ILF3 HNRNPA3	6.88e-05	712	10	5	MP:0011089
MousePheno	neonatal lethality	MEX3B AMOTL1 FUS ILF3 HNRNPA3	1.19e-04	799	10	5	MP:0002058
MousePheno	increased mortality induced by gamma-irradiation	EWSR1 FUS	3.03e-04	37	10	2	MP:0001658
MousePheno	neonatal lethality, complete penetrance	AMOTL1 FUS ILF3 HNRNPA3	3.68e-04	534	10	4	MP:0011087
MousePheno	abnormal cerebral hemisphere morphology	ARID1B SS18L1 FUS HNRNPA3	5.70e-04	599	10	4	MP:0008540
MousePheno	increased mortality induced by ionizing radiation	EWSR1 FUS	5.76e-04	51	10	2	MP:0003992
MousePheno	abnormal mortality induced by ionizing radiation	EWSR1 FUS	6.70e-04	55	10	2	MP:0020149
MousePheno	abnormal response to radiation	EWSR1 FUS	7.20e-04	57	10	2	MP:0012734
MousePheno	lethality during fetal growth through weaning, complete penetrance	ARID1B AMOTL1 FUS ILF3 HNRNPA3	1.04e-03	1269	10	5	MP:0011111
MousePheno	abnormal hippocampus pyramidal cell layer	ARID1B FUS	1.11e-03	71	10	2	MP:0008284
MousePheno	abnormal cerebral cortex morphology	ARID1B SS18L1 HNRNPA3	1.36e-03	328	10	3	MP:0000788
MousePheno	abnormal hippocampus morphology	ARID1B SS18L1 FUS	1.40e-03	331	10	3	MP:0000807
MousePheno	abnormal temporal lobe morphology	ARID1B SS18L1 FUS	1.47e-03	337	10	3	MP:0000801
MousePheno	abnormal telencephalon morphology	ARID1B SS18L1 FUS HNRNPA3	1.79e-03	812	10	4	MP:0000787
MousePheno	abnormal hippocampus layer morphology	ARID1B FUS	1.86e-03	92	10	2	MP:0000813
MousePheno	abnormal limbic system morphology	ARID1B SS18L1 FUS	2.04e-03	378	10	3	MP:0004166
MousePheno	thin cerebral cortex	ARID1B HNRNPA3	2.20e-03	100	10	2	MP:0006254
Domain	-	EWSR1 TAF15 FUS	3.15e-08	10	13	3	4.10.1060.10
Domain	RRM_1	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	1.95e-07	208	13	5	PF00076
Domain	RRM	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	2.41e-07	217	13	5	SM00360
Domain	RRM_dom	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	3.02e-07	227	13	5	IPR000504
Domain	RRM	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	3.22e-07	230	13	5	PS50102
Domain	zf-RanBP	EWSR1 TAF15 FUS	4.03e-07	22	13	3	PF00641
Domain	-	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	4.32e-07	244	13	5	3.30.70.330
Domain	ZnF_RBZ	EWSR1 TAF15 FUS	4.63e-07	23	13	3	SM00547
Domain	ZF_RANBP2_2	EWSR1 TAF15 FUS	4.63e-07	23	13	3	PS50199
Domain	ZF_RANBP2_1	EWSR1 TAF15 FUS	5.29e-07	24	13	3	PS01358
Domain	Nucleotide-bd_a/b_plait	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	5.69e-07	258	13	5	IPR012677
Domain	Znf_RanBP2	EWSR1 TAF15 FUS	6.01e-07	25	13	3	IPR001876
Domain	-	MEX3B ZMIZ1	3.78e-02	449	13	2	3.30.40.10
Domain	Znf_RING/FYVE/PHD	MEX3B ZMIZ1	3.93e-02	459	13	2	IPR013083
Pathway	WP_MRNA_PROCESSING	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	4.18e-07	451	11	6	MM15946
Pathway	REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION	ARID1B SS18L1	4.69e-04	42	11	2	M48237
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.20e-11	336	13	7	31253590
Pubmed	mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	21344536
Pubmed	Characterization of a new brain-specific isoform of the EWS oncoprotein.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	11422378
Pubmed	The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	18620564
Pubmed	O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	27903134
Pubmed	A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	23975937
Pubmed	Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	23049996
Pubmed	Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	27311318
Pubmed	FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	21856723
Pubmed	Role of FET proteins in neurodegenerative disorders.	EWSR1 TAF15 FUS	4.08e-11	3	13	3	27415968
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	HNRNPDL EWSR1 TAF15 SS18L1 FUS ILF3 HNRNPA3	5.84e-11	421	13	7	34650049
Pubmed	TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	6.77e-11	430	13	7	38172120
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	HNRNPDL EWSR1 TAF15 ARID1B SS18L1 FUS ILF3	9.74e-11	453	13	7	29656893
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	EWSR1 TAF15 ARID1B FUS	1.03e-10	23	13	4	30962207
Pubmed	Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.	EWSR1 TAF15 FUS HNRNPA3	1.03e-10	23	13	4	18320585
Pubmed	Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation.	EWSR1 TAF15 FUS	1.63e-10	4	13	3	28453628
Pubmed	The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.	EWSR1 TAF15 FUS	1.63e-10	4	13	3	9660765
Pubmed	Characterization of TFG in mus musculus and Caenorhabditis elegans.	TFG EWSR1 FUS	1.63e-10	4	13	3	10092511
Pubmed	The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.	EWSR1 TAF15 FUS	1.63e-10	4	13	3	30398641
Pubmed	CHK2-BRCA1 tumor-suppressor axis restrains oncogenic Aurora-A kinase to ensure proper mitotic microtubule assembly.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.78e-10	494	13	7	26831064
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.85e-10	244	13	6	29884807
Pubmed	Identifying and quantifying in vivo methylation sites by heavy methyl SILAC.	EWSR1 TAF15 FUS ILF3	3.20e-10	30	13	4	15782174
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	HNRNPDL EWSR1 TAF15 ARID1B SS18L1 FUS ILF3 HNRNPA3	3.55e-10	954	13	8	36373674
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	3.81e-10	551	13	7	34728620
Pubmed	Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.	EWSR1 TAF15 FUS	8.15e-10	6	13	3	18509338
Pubmed	The hnRNP RALY regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.	EWSR1 TAF15 FUS	8.15e-10	6	13	3	30354839
Pubmed	Landscape of the SOX2 protein-protein interactome.	EWSR1 TAF15 FUS ILF3 HNRNPA3	1.07e-09	136	13	5	21280222
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.35e-09	340	13	6	24332808
Pubmed	hnRNPA1 couples nuclear export and translation of specific mRNAs downstream of FGF-2/S6K2 signalling.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.50e-09	346	13	6	25324306
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.53e-09	347	13	6	16033648
Pubmed	The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer.	HNRNPDL TAF15 FUS ILF3 HNRNPA3	1.58e-09	147	13	5	28977470
Pubmed	Proteomic analysis of the cullin 4B interactome using proximity-dependent biotinylation in living cells.	HNRNPDL EWSR1 TAF15 ILF3 HNRNPA3	1.93e-09	153	13	5	28225217
Pubmed	Prohibitin 1 regulates tumor cell apoptosis via the interaction with X-linked inhibitor of apoptosis protein.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	2.56e-09	725	13	7	27025967
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.52e-09	399	13	6	35987950
Pubmed	The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.	HNRNPDL MEX3B EWSR1 TAF15 FUS ILF3 HNRNPA3	5.36e-09	807	13	7	22681889
Pubmed	Epidermal progenitors suppress GRHL3-mediated differentiation through intronic polyadenylation promoted by CPSF-HNRNPA3 collaboration.	TAF15 FUS HNRNPA3	6.72e-09	11	13	3	33469008
Pubmed	Host cell interactome of HIV-1 Rev includes RNA helicases involved in multiple facets of virus production.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	8.60e-09	206	13	5	22174317
Pubmed	LINKIN, a new transmembrane protein necessary for cell adhesion.	HNRNPDL TFG EWSR1 FUS ILF3 HNRNPA3	1.06e-08	480	13	6	25437307
Pubmed	Ki-1/57 interacts with PRMT1 and is a substrate for arginine methylation.	EWSR1 ILF3 HNRNPA3	1.85e-08	15	13	3	16879614
Pubmed	Regulation of PKD by the MAPK p38delta in insulin secretion and glucose homeostasis.	TFG TAF15 FUS ILF3	2.23e-08	84	13	4	19135240
Pubmed	Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms.	HNRNPDL TFG EWSR1 FUS HNRNPA3	2.55e-08	256	13	5	24189400
Pubmed	SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	2.65e-08	258	13	5	37794589
Pubmed	Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.	EWSR1 FUS ZMIZ1 HNRNPA3	2.69e-08	88	13	4	26318153
Pubmed	Circular RNA circPVT1 promotes nasopharyngeal carcinoma metastasis via the β-TrCP/c-Myc/SRSF1 positive feedback loop.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	2.75e-08	260	13	5	36199071
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	2.76e-08	1024	13	7	24711643
Pubmed	Cleavage and polyadenylation specificity factor 1 (CPSF1) regulates alternative splicing of interleukin 7 receptor (IL7R) exon 6.	HNRNPDL FUS ILF3 HNRNPA3	2.94e-08	90	13	4	23151878
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	4.18e-08	605	13	6	28977666
Pubmed	WWP2 ubiquitylates RNA polymerase II for DNA-PK-dependent transcription arrest and repair at DNA breaks.	EWSR1 TAF15 ARID1B AMOTL1 ILF3 HNRNPA3	4.61e-08	615	13	6	31048545
Pubmed	Tumor suppressor BAP1 nuclear import is governed by transportin-1.	HNRNPDL TFG EWSR1 AMOTL1 FUS ILF3 HNRNPA3	6.08e-08	1149	13	7	35446349
Pubmed	The HIV-1 Tat protein recruits a ubiquitin ligase to reorganize the 7SK snRNP for transcriptional activation.	HNRNPDL EWSR1 TAF15 ARID1B FUS ILF3 HNRNPA3	6.23e-08	1153	13	7	29845934
Pubmed	Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication.	HNRNPDL EWSR1 ILF3 HNRNPA3	9.73e-08	121	13	4	34029587
Pubmed	Mutual regulation between OGT and XIAP to control colon cancer cell growth and invasion.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3	1.02e-07	704	13	6	32994395
Pubmed	BPA modulates the WDR5/TET2 complex to regulate ERβ expression in eutopic endometrium and drives the development of endometriosis.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.09e-07	711	13	6	33022573
Pubmed	C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains.	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.12e-07	1257	13	7	37317656
Pubmed	The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors.	HNRNPDL EWSR1 TAF15 AMOTL1 HNRNPA3	1.21e-07	350	13	5	26549023
Pubmed	EWS and FUS bind a subset of transcribed genes encoding proteins enriched in RNA regulatory functions.	EWSR1 FUS	1.29e-07	2	13	2	26573619
Pubmed	Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.	TAF15 FUS	1.29e-07	2	13	2	9795213
Pubmed	Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.	EWSR1 TAF15	1.29e-07	2	13	2	22454397
Pubmed	A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.	EWSR1 FUS	1.29e-07	2	13	2	31994243
Pubmed	Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS.	EWSR1 FUS	1.29e-07	2	13	2	8921363
Pubmed	Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.	EWSR1 TAF15	1.29e-07	2	13	2	8954779
Pubmed	Immunoprecipitation and mass spectrometry defines an extensive RBM45 protein-protein interaction network.	HNRNPDL FUS ILF3 HNRNPA3	1.56e-07	136	13	4	26979993
Pubmed	Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis.	TFG EWSR1 ARID1B FUS ILF3 HNRNPA3	2.29e-07	807	13	6	30575818
Pubmed	Wnt regulation: exploring Axin-Disheveled interactions and defining mechanisms by which the SCF E3 ubiquitin ligase is recruited to the destruction complex.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	2.32e-07	809	13	6	32129710
Pubmed	WW domains provide a platform for the assembly of multiprotein networks.	TFG EWSR1 AMOTL1 FUS	2.56e-07	154	13	4	16055720
Pubmed	Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.	EWSR1 FUS ILF3 HNRNPA3	2.91e-07	159	13	4	22751105
Pubmed	Quantitative Proteomics Reveals Dynamic Interactions of the Minichromosome Maintenance Complex (MCM) in the Cellular Response to Etoposide Induced DNA Damage.	TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	2.98e-07	844	13	6	25963833
Pubmed	Proteomic Analysis of the EWS-Fli-1 Interactome Reveals the Role of the Lysosome in EWS-Fli-1 Turnover.	HNRNPDL TFG EWSR1 FUS HNRNPA3	3.16e-07	425	13	5	24999758
Pubmed	Targeted and Interactome Proteomics Revealed the Role of PHD2 in Regulating BRD4 Proline Hydroxylation.	HNRNPDL TAF15 FUS ILF3 HNRNPA3	3.79e-07	441	13	5	31239290
Pubmed	Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.	EWSR1 FUS	3.87e-07	3	13	2	25706482
Pubmed	Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.	EWSR1 TAF15	3.87e-07	3	13	2	12359745
Pubmed	NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.	EWSR1 TAF15	3.87e-07	3	13	2	31020999
Pubmed	FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts.	EWSR1 FUS	3.87e-07	3	13	2	32991339
Pubmed	Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.	EWSR1 FUS	3.87e-07	3	13	2	26690869
Pubmed	Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS.	TAF15 FUS	3.87e-07	3	13	2	24474660
Pubmed	Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.	EWSR1 FUS	3.87e-07	3	13	2	38168093
Pubmed	Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.	EWSR1 FUS	3.87e-07	3	13	2	34049318
Pubmed	Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.	TAF15 FUS	3.87e-07	3	13	2	27460707
Pubmed	A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.	EWSR1 FUS	3.87e-07	3	13	2	28505004
Pubmed	Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.	EWSR1 FUS	3.87e-07	3	13	2	33859361
Pubmed	EWSR1-induced circNEIL3 promotes glioma progression and exosome-mediated macrophage immunosuppressive polarization via stabilizing IGF2BP3.	HNRNPDL EWSR1 FUS HNRNPA3	4.18e-07	174	13	4	35031058
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TFG EWSR1 ARID1B FUS ZMIZ1	4.52e-07	457	13	5	32344865
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	4.77e-07	462	13	5	31138677
Pubmed	TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions.	HNRNPDL TFG EWSR1 ARID1B AMOTL1 HNRNPA3	5.00e-07	922	13	6	27609421
Pubmed	A novel role for the peptidyl-prolyl cis-trans isomerase Cyclophilin A in DNA-repair following replication fork stalling via the MRE11-RAD50-NBS1 complex.	HNRNPDL TFG ARID1B FUS ILF3	5.30e-07	472	13	5	38943005
Pubmed	Revealing A-Raf functions through its interactome.	EWSR1 TAF15 FUS ILF3	5.57e-07	187	13	4	29777862
Pubmed	ZF21 is a new regulator of focal adhesion disassembly and a potential member of the spreading initiation center.	EWSR1 TAF15 FUS	6.14e-07	46	13	3	20890123
Pubmed	Proteomic analysis of α4β1 integrin adhesion complexes reveals α-subunit-dependent protein recruitment.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	6.44e-07	491	13	5	22623428
Pubmed	MYC multimers shield stalled replication forks from RNA polymerase.	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	7.53e-07	989	13	6	36424410
Pubmed	Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.	TAF15 FUS	7.74e-07	4	13	2	25062688
Pubmed	Interactomic analysis of REST/NRSF and implications of its functional links with the transcription suppressor TRIM28 during neuronal differentiation.	EWSR1 TAF15 ILF3 HNRNPA3	8.04e-07	205	13	4	27976729
Pubmed	SARS-CoV-2 spike protein induces endothelial inflammation via ACE2 independently of viral replication.	HNRNPDL FUS ILF3 HNRNPA3	9.90e-07	216	13	4	37640791
Pubmed	The Deubiquitinating Enzyme USP48 Interacts with the Retinal Degeneration-Associated Proteins UNC119a and ARL3.	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	1.15e-06	552	13	5	36293380
Pubmed	IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.	HNRNPDL ILF3 HNRNPA3	1.24e-06	58	13	3	21642987
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	EWSR1 TAF15 ARID1B SS18L1 ILF3 HNRNPA3	1.27e-06	1082	13	6	38697112
Pubmed	Distinct and shared functions of ALS-associated proteins TDP-43, FUS and TAF15 revealed by multisystem analyses.	TAF15 FUS	1.29e-06	5	13	2	27378374
Pubmed	IGF1 is a common target gene of Ewing's sarcoma fusion proteins in mesenchymal progenitor cells.	EWSR1 FUS	1.29e-06	5	13	2	18648544
Pubmed	Characterization of two evolutionarily conserved, alternatively spliced nuclear phosphoproteins, NFAR-1 and -2, that function in mRNA processing and interact with the double-stranded RNA-dependent protein kinase, PKR.	FUS ILF3	1.29e-06	5	13	2	11438536
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	HNRNPDL FUS ILF3 HNRNPA3	1.32e-06	232	13	4	25515538
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	HNRNPDL EWSR1 ARID1B FUS ILF3 HNRNPA3	1.42e-06	1103	13	6	34189442
Interaction	DCUN1D1 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.31e-10	275	13	7	int:DCUN1D1
Interaction	ARIH2 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	3.30e-10	314	13	7	int:ARIH2
Interaction	MYCN interactions	HNRNPDL TFG MEX3B EWSR1 TAF15 ARID1B SS18L1 FUS ILF3 HNRNPA3	4.94e-10	1373	13	10	int:MYCN
Interaction	CUL2 interactions	HNRNPDL TFG EWSR1 TAF15 ARID1B FUS ILF3 HNRNPA3	5.90e-10	591	13	8	int:CUL2
Interaction	NEDD8 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.58e-09	393	13	7	int:NEDD8
Interaction	NUP35 interactions	TFG EWSR1 ARID1B FUS ILF3 ZMIZ1 HNRNPA3	2.67e-09	424	13	7	int:NUP35
Interaction	SNRPC interactions	HNRNPDL EWSR1 TAF15 SS18L1 FUS ILF3 HNRNPA3	3.46e-09	440	13	7	int:SNRPC
Interaction	TRIM31 interactions	HNRNPDL EWSR1 TAF15 SS18L1 FUS ILF3 HNRNPA3	4.29e-09	454	13	7	int:TRIM31
Interaction	RBMX interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	4.77e-09	461	13	7	int:RBMX
Interaction	SNRPB interactions	HNRNPDL EWSR1 TAF15 SS18L1 FUS ILF3 HNRNPA3	1.05e-08	517	13	7	int:SNRPB
Interaction	CELF1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.28e-08	288	13	6	int:CELF1
Interaction	TP53BP1 interactions	HNRNPDL EWSR1 TAF15 ARID1B SS18L1 FUS ILF3	1.30e-08	533	13	7	int:TP53BP1
Interaction	CAND1 interactions	HNRNPDL TFG EWSR1 TAF15 ARID1B FUS ILF3 HNRNPA3	1.53e-08	894	13	8	int:CAND1
Interaction	FAM168A interactions	TFG EWSR1 ARID1B SS18L1 AMOTL1	1.99e-08	142	13	5	int:FAM168A
Interaction	CUL5 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.99e-08	567	13	7	int:CUL5
Interaction	PRMT1 interactions	HNRNPDL TFG MEX3B EWSR1 TAF15 FUS ILF3 HNRNPA3	2.07e-08	929	13	8	int:PRMT1
Interaction	SMC5 interactions	HNRNPDL EWSR1 TAF15 ARID1B SS18L1 FUS ILF3 HNRNPA3	3.68e-08	1000	13	8	int:SMC5
Interaction	SNRNP40 interactions	HNRNPDL EWSR1 TAF15 ARID1B FUS ILF3 HNRNPA3	4.44e-08	637	13	7	int:SNRNP40
Interaction	HNRNPDL interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	5.14e-08	364	13	6	int:HNRNPDL
Interaction	FLI1 interactions	EWSR1 TAF15 ARID1B FUS	5.69e-08	62	13	4	int:FLI1
Interaction	HNRNPAB interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	5.75e-08	371	13	6	int:HNRNPAB
Interaction	TAF15 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.01e-07	408	13	6	int:TAF15
Interaction	CUL4B interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.11e-07	728	13	7	int:CUL4B
Interaction	DDX17 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.30e-07	426	13	6	int:DDX17
Interaction	RBM45 interactions	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	1.31e-07	207	13	5	int:RBM45
Interaction	BRCA1 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 ZMIZ1 HNRNPA3	2.07e-07	1249	13	8	int:BRCA1
Interaction	DDX1 interactions	HNRNPDL MEX3B EWSR1 TAF15 FUS ILF3	2.13e-07	463	13	6	int:DDX1
Interaction	LARP1 interactions	HNRNPDL TFG TAF15 FUS ILF3 HNRNPA3	2.19e-07	465	13	6	int:LARP1
Interaction	SNRPA interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	2.70e-07	482	13	6	int:SNRPA
Interaction	RNU1-1 interactions	EWSR1 TAF15 FUS	2.77e-07	21	13	3	int:RNU1-1
Interaction	CUL7 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	3.06e-07	845	13	7	int:CUL7
Interaction	DHX15 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.43e-07	502	13	6	int:DHX15
Interaction	HNRNPA3 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.81e-07	511	13	6	int:HNRNPA3
Interaction	CUL1 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	3.90e-07	876	13	7	int:CUL1
Interaction	PSPC1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.99e-07	515	13	6	int:PSPC1
Interaction	LSM14A interactions	HNRNPDL MEX3B TAF15 ILF3 HNRNPA3	4.07e-07	260	13	5	int:LSM14A
Interaction	TARDBP interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	4.22e-07	520	13	6	int:TARDBP
Interaction	CPSF6 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	4.51e-07	526	13	6	int:CPSF6
Interaction	PRMT8 interactions	EWSR1 TAF15 FUS HNRNPA3	4.62e-07	104	13	4	int:PRMT8
Interaction	EWSR1 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	4.91e-07	906	13	7	int:EWSR1
Interaction	HEXIM1 interactions	HNRNPDL EWSR1 TAF15 ARID1B FUS ILF3 HNRNPA3	5.17e-07	913	13	7	int:HEXIM1
Interaction	ITFG1 interactions	HNRNPDL TFG EWSR1 FUS ILF3 HNRNPA3	5.26e-07	540	13	6	int:ITFG1
Interaction	ARID1A interactions	EWSR1 TAF15 ARID1B SS18L1 FUS	5.47e-07	276	13	5	int:ARID1A
Interaction	DDX5 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	7.08e-07	568	13	6	int:DDX5
Interaction	SCARNA22 interactions	EWSR1 FUS ILF3 HNRNPA3	7.67e-07	118	13	4	int:SCARNA22
Interaction	UPF1 interactions	HNRNPDL MEX3B EWSR1 FUS ILF3 HNRNPA3	8.08e-07	581	13	6	int:UPF1
Interaction	DDIT3 interactions	EWSR1 TAF15 ARID1B FUS	8.20e-07	120	13	4	int:DDIT3
Interaction	BRD7 interactions	HNRNPDL EWSR1 ARID1B SS18L1 ILF3 HNRNPA3	1.38e-06	637	13	6	int:BRD7
Interaction	HNRNPD interactions	HNRNPDL EWSR1 FUS ILF3 ZMIZ1 HNRNPA3	1.40e-06	638	13	6	int:HNRNPD
Interaction	SUZ12 interactions	MEX3B EWSR1 TAF15 AMOTL1 FUS ILF3	1.47e-06	644	13	6	int:SUZ12
Interaction	IL7R interactions	HNRNPDL FUS ILF3 HNRNPA3	1.56e-06	141	13	4	int:IL7R
Interaction	U2AF2 interactions	HNRNPDL MEX3B EWSR1 TAF15 ILF3 HNRNPA3	1.57e-06	651	13	6	int:U2AF2
Interaction	SF3B4 interactions	TFG EWSR1 SS18L1 FUS ILF3	1.57e-06	342	13	5	int:SF3B4
Interaction	MATR3 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.63e-06	655	13	6	int:MATR3
Interaction	BMI1 interactions	EWSR1 TAF15 SS18L1 FUS ILF3 HNRNPA3	1.69e-06	659	13	6	int:BMI1
Interaction	SNRPD1 interactions	EWSR1 TAF15 FUS ILF3 HNRNPA3	1.69e-06	347	13	5	int:SNRPD1
Interaction	DHX9 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.73e-06	662	13	6	int:DHX9
Interaction	DAZL interactions	HNRNPDL TAF15 ILF3 HNRNPA3	1.75e-06	145	13	4	int:DAZL
Interaction	HNRNPUL1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3	1.79e-06	351	13	5	int:HNRNPUL1
Interaction	RC3H2 interactions	HNRNPDL MEX3B EWSR1 TAF15 FUS ILF3	1.81e-06	667	13	6	int:RC3H2
Interaction	SMARCC2 interactions	EWSR1 TAF15 ARID1B SS18L1 FUS	1.84e-06	353	13	5	int:SMARCC2
Interaction	COPS5 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	1.84e-06	1102	13	7	int:COPS5
Interaction	RC3H1 interactions	HNRNPDL MEX3B EWSR1 FUS ILF3 HNRNPA3	1.97e-06	677	13	6	int:RC3H1
Interaction	WDR77 interactions	HNRNPDL TAF15 FUS ILF3 HNRNPA3	2.05e-06	361	13	5	int:WDR77
Interaction	PHB1 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	2.09e-06	1123	13	7	int:PHB1
Interaction	PABPC1 interactions	HNRNPDL MEX3B TAF15 FUS ILF3 HNRNPA3	2.37e-06	699	13	6	int:PABPC1
Interaction	MRPS9 interactions	HNRNPDL MEX3B EWSR1 AMOTL1 ILF3	2.71e-06	382	13	5	int:MRPS9
Interaction	SMARCC1 interactions	EWSR1 TAF15 ARID1B SS18L1 FUS	2.78e-06	384	13	5	int:SMARCC1
Interaction	SNRPF interactions	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	2.81e-06	385	13	5	int:SNRPF
Interaction	SYNCRIP interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	2.84e-06	721	13	6	int:SYNCRIP
Interaction	HNRNPM interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	2.89e-06	723	13	6	int:HNRNPM
Interaction	CSTF2 interactions	TFG EWSR1 SS18L1 FUS	2.92e-06	165	13	4	int:CSTF2
Interaction	MAPK1IP1L interactions	TFG EWSR1 SS18L1	2.93e-06	45	13	3	int:MAPK1IP1L
Interaction	HNRNPA2B1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.68e-06	754	13	6	int:HNRNPA2B1
Interaction	COPS6 interactions	HNRNPDL TFG EWSR1 TAF15 FUS	3.74e-06	408	13	5	int:COPS6
Interaction	FUS interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.77e-06	757	13	6	int:FUS
Interaction	CHD3 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	3.77e-06	757	13	6	int:CHD3
Interaction	GATA4 interactions	EWSR1 TAF15 FUS ILF3 HNRNPA3	3.87e-06	411	13	5	int:GATA4
Interaction	XAB2 interactions	EWSR1 TAF15 FUS ILF3	4.71e-06	186	13	4	int:XAB2
Interaction	MECP2 interactions	EWSR1 TAF15 ARID1B SS18L1 FUS ILF3 HNRNPA3	5.20e-06	1287	13	7	int:MECP2
Interaction	PABPC4 interactions	HNRNPDL MEX3B TAF15 FUS ILF3	5.52e-06	442	13	5	int:PABPC4
Interaction	BAP1 interactions	HNRNPDL TFG EWSR1 AMOTL1 FUS ILF3 HNRNPA3	5.97e-06	1314	13	7	int:BAP1
Interaction	C9orf72 interactions	HNRNPDL TFG EWSR1 TAF15 FUS ILF3 HNRNPA3	6.12e-06	1319	13	7	int:C9orf72
Interaction	SMARCA4 interactions	EWSR1 TAF15 ARID1B SS18L1 FUS	6.85e-06	462	13	5	int:SMARCA4
Interaction	WWP2 interactions	EWSR1 TAF15 ARID1B AMOTL1 ILF3 HNRNPA3	6.87e-06	840	13	6	int:WWP2
Interaction	TRIP4 interactions	MEX3B EWSR1 FUS ILF3	7.05e-06	206	13	4	int:TRIP4
Interaction	NFX1 interactions	HNRNPDL MEX3B FUS ILF3 HNRNPA3	7.14e-06	466	13	5	int:NFX1
Interaction	HNRNPK interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	7.51e-06	853	13	6	int:HNRNPK
Interaction	MEPCE interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	7.82e-06	859	13	6	int:MEPCE
Interaction	SRPK1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3	8.00e-06	477	13	5	int:SRPK1
Interaction	SSB interactions	HNRNPDL TFG EWSR1 ILF3 HNRNPA3	8.59e-06	484	13	5	int:SSB
Interaction	PPIA interactions	HNRNPDL TFG EWSR1 ARID1B FUS ILF3	9.46e-06	888	13	6	int:PPIA
Interaction	ERG interactions	HNRNPDL ARID1B SS18L1 ILF3	9.65e-06	223	13	4	int:ERG
Interaction	BICRA interactions	EWSR1 ARID1B SS18L1	9.81e-06	67	13	3	int:BICRA
Interaction	SRSF9 interactions	HNRNPDL EWSR1 TAF15 FUS	9.82e-06	224	13	4	int:SRSF9
Interaction	ZNF326 interactions	EWSR1 TAF15 FUS ILF3	9.82e-06	224	13	4	int:ZNF326
Interaction	ILF3 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	9.96e-06	896	13	6	int:ILF3
Interaction	MIR138-1 interactions	TAF15 FUS HNRNPA3	1.03e-05	68	13	3	int:MIR138-1
Interaction	OBSL1 interactions	HNRNPDL EWSR1 TAF15 FUS ILF3 HNRNPA3	1.03e-05	902	13	6	int:OBSL1
Interaction	IGF2BP1 interactions	HNRNPDL MEX3B FUS ILF3 HNRNPA3	1.09e-05	508	13	5	int:IGF2BP1
Cytoband	Ensembl 112 genes in cytogenetic band chr20q13	WFDC6 SS18L1	6.15e-03	422	13	2	chr20q13
GeneFamily	RNA binding motif containing	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	2.63e-08	213	9	5	725
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	EWSR1 TAF15 FUS	1.13e-07	21	9	3	89
Coexpression	HAY_BONE_MARROW_PRO_B	HNRNPDL EWSR1 AMOTL1 FUS HNRNPA3	2.42e-07	304	13	5	M39208
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	TFG EWSR1 TAF15 SS18L1 FUS	3.27e-07	323	13	5	M9150
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HNRNPDL SS18L1 FUS ILF3 ZMIZ1	1.81e-06	457	13	5	M1613
Coexpression	MILI_PSEUDOPODIA_CHEMOTAXIS_DN	HNRNPDL SS18L1 FUS ILF3 ZMIZ1	2.07e-06	470	13	5	MM1053
Coexpression	GSE23114_PERITONEAL_CAVITY_B1A_BCELL_VS_SPLEEN_BCELL_DN	HNRNPDL SS18L1 FUS HNRNPA3	2.23e-06	200	13	4	M8297
Coexpression	GSE5099_MONOCYTE_VS_CLASSICAL_M1_MACROPHAGE_DN	HNRNPDL EWSR1 FUS ILF3	2.23e-06	200	13	4	M6587
Coexpression	BENPORATH_SOX2_TARGETS	TAF15 ARID1B AMOTL1 FUS ILF3	1.81e-05	734	13	5	M3835
Coexpression	HEVNER_VENTRICULAR_ZONE_AND_UP_NEURON_FATE_COMMITTED_CELLS	ARID1B SS18L1	2.38e-05	15	13	2	MM410
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	HNRNPDL EWSR1 ILF3 HNRNPA3	4.71e-05	434	13	4	M15150
Coexpression	ZHANG_BREAST_CANCER_PROGENITORS_UP	HNRNPDL EWSR1 ILF3 HNRNPA3	5.33e-05	448	13	4	MM1044
Coexpression	FISCHER_DREAM_TARGETS	HNRNPDL EWSR1 FUS ILF3 HNRNPA3	6.86e-05	969	13	5	M149
Coexpression	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	HNRNPDL MEX3B FUS	7.57e-05	172	13	3	M17811
Coexpression	PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN	HNRNPDL MEX3B FUS	7.70e-05	173	13	3	MM580
Coexpression	GSE16385_IL4_VS_ROSIGLITAZONE_STIM_MACROPHAGE_UP	MEX3B ILF3 ZMIZ1	1.08e-04	194	13	3	M8017
Coexpression	GSE36826_NORMAL_VS_STAPH_AUREUS_INF_IL1R_KO_SKIN_DN	ILF3 ZMIZ1 HNRNPA3	1.17e-04	199	13	3	M9532
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_NKTCELL_UP	HNRNPDL FUS HNRNPA3	1.18e-04	200	13	3	M8312
Coexpression	GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_UP	HNRNPDL FUS HNRNPA3	1.18e-04	200	13	3	M8305
Coexpression	GSE22140_GERMFREE_VS_SPF_MOUSE_CD4_TCELL_DN	EWSR1 FUS HNRNPA3	1.18e-04	200	13	3	M7644
Coexpression	GSE34515_CD16_POS_MONOCYTE_VS_DC_UP	HNRNPDL FUS ZMIZ1	1.18e-04	200	13	3	M8765
Coexpression	CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_DN	TAF15 FUS ILF3 HNRNPA3	2.50e-04	669	13	4	M18635
Coexpression	TABULA_MURIS_SENIS_LARGE_INTESTINE_SECRETORY_CELL_AGEING	TFG EWSR1 FUS HNRNPA3	3.56e-04	734	13	4	MM3740
Coexpression	MANALO_HYPOXIA_DN	HNRNPDL FUS ILF3	3.60e-04	292	13	3	M18562
Coexpression	ZHAN_MULTIPLE_MYELOMA_UP	EWSR1 ILF3	4.50e-04	64	13	2	M3958
Coexpression	FAN_OVARY_CL1_GPRC5A_TNFRS12A_HIGH_SELECTABLE_FOLLICLE_STROMAL_CELL	HNRNPDL EWSR1 HNRNPA3	7.76e-04	380	13	3	M41703
Coexpression	MOHANKUMAR_HOXA1_TARGETS_UP	FUS ILF3 ZMIZ1	9.67e-04	410	13	3	M4399
Coexpression	BENPORATH_NANOG_TARGETS	ARID1B AMOTL1 FUS ILF3	1.09e-03	988	13	4	M6616
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN	FUS ILF3 HNRNPA3	1.12e-03	432	13	3	M41149
Coexpression	GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS	MEX3B EWSR1 ZMIZ1 HNRNPA3	1.18e-03	1009	13	4	M157
Coexpression	TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C	FUS ILF3 HNRNPA3	1.30e-03	454	13	3	M19927
Coexpression	WHITEFORD_PEDIATRIC_CANCER_MARKERS	MEX3B ILF3	1.49e-03	117	13	2	M7854
Coexpression	TABULA_MURIS_SENIS_SPLEEN_PROERYTHROBLAST_AGEING	HNRNPDL EWSR1 FUS HNRNPA3	1.88e-03	1144	13	4	MM3843
Coexpression	JIANG_MELANOMA_TRM9_CD8	HNRNPDL FUS HNRNPA3	1.98e-03	526	13	3	M48973
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN	HNRNPDL ARID1B ZMIZ1	2.15e-03	542	13	3	M19529
Coexpression	RYAN_MANTLE_CELL_LYMPHOMA_NOTCH_DIRECT_UP	ARID1B ZMIZ1	2.37e-03	148	13	2	M39016
Coexpression	DOUGLAS_BMI1_TARGETS_UP	ARID1B SS18L1 ILF3	2.40e-03	563	13	3	M15103
Coexpression	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	TAF15 FUS	2.53e-03	153	13	2	M438
Coexpression	GSE10147_IL3_AND_HIVP17_VS_IL3_AND_CPG_STIM_PDC_DN	MEX3B ILF3	2.53e-03	153	13	2	M350
Coexpression	CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP	ILF3 HNRNPA3	2.83e-03	162	13	2	M45037
Coexpression	GAUTAM_EYE_CORNEA_FIBROBLASTS	HNRNPDL FUS	2.94e-03	165	13	2	M43617
Coexpression	GSE15624_3H_VS_6H_HALOFUGINONE_TREATED_CD4_TCELL_UP	ARID1B FUS	3.15e-03	171	13	2	M7105
Coexpression	GSE14415_TCONV_VS_FOXP3_KO_INDUCED_TREG_UP	HNRNPDL FUS	3.18e-03	172	13	2	M2963
Coexpression	GSE27896_HDAC6_KO_VS_WT_TREG_UP	ARID1B SS18L1	3.33e-03	176	13	2	M8248
Coexpression	BENPORATH_NOS_TARGETS	ARID1B FUS	3.44e-03	179	13	2	M14573
Coexpression	FAN_OVARY_CL15_SMALL_ANTRAL_FOLLICLE_GRANULOSA_CELL	HNRNPDL TFG EWSR1	3.51e-03	644	13	3	M41717
Coexpression	GSE18791_UNSTIM_VS_NEWCATSLE_VIRUS_DC_2H_DN	MEX3B SS18L1	3.59e-03	183	13	2	M4289
Coexpression	PUJANA_ATM_PCC_NETWORK	EWSR1 FUS ILF3 HNRNPA3	3.87e-03	1394	13	4	M9585
Coexpression	GSE43863_NAIVE_VS_TFH_CD4_EFF_TCELL_D6_LCMV_DN	WFDC6 ARID1B	3.99e-03	193	13	2	M9727
Coexpression	GSE22886_CD8_VS_CD4_NAIVE_TCELL_DN	TAF15 ILF3	4.11e-03	196	13	2	M4404
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_2H_UP	FUS ZMIZ1	4.15e-03	197	13	2	M6125
Coexpression	GSE37416_0H_VS_3H_F_TULARENSIS_LVS_NEUTROPHIL_DN	TFG ZMIZ1	4.15e-03	197	13	2	M5342
Coexpression	GSE16450_CTRL_VS_IFNA_12H_STIM_IMMATURE_NEURON_CELL_LINE_UP	FUS HNRNPA3	4.15e-03	197	13	2	M7403
Coexpression	GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_DN	TAF15 FUS	4.19e-03	198	13	2	M7460
Coexpression	GSE2770_IL12_AND_TGFB_ACT_VS_ACT_CD4_TCELL_6H_DN	TFG FUS	4.19e-03	198	13	2	M6068
Coexpression	GSE14308_TH17_VS_NAIVE_CD4_TCELL_DN	EWSR1 FUS	4.23e-03	199	13	2	M3384
Coexpression	GSE11924_TFH_VS_TH17_CD4_TCELL_UP	TAF15 ILF3	4.23e-03	199	13	2	M3156
Coexpression	GSE37416_0H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_DN	TFG ZMIZ1	4.23e-03	199	13	2	M5350
Coexpression	GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_16H_UP	HNRNPDL TAF15	4.23e-03	199	13	2	M8266
Coexpression	GSE11961_MEMORY_BCELL_DAY7_VS_GERMINAL_CENTER_BCELL_DAY40_DN	MEX3B ZMIZ1	4.23e-03	199	13	2	M9359
Coexpression	GSE41867_DAY15_EFFECTOR_VS_DAY30_MEMORY_CD8_TCELL_LCMV_ARMSTRONG_UP	ARID1B ZMIZ1	4.23e-03	199	13	2	M9523
Coexpression	GSE12392_IFNAR_KO_VS_IFNB_KO_CD8_NEG_SPLEEN_DC_UP	EWSR1 ZMIZ1	4.23e-03	199	13	2	M7142
Coexpression	GSE23505_IL6_IL1_IL23_VS_IL6_IL1_TGFB_TREATED_CD4_TCELL_DN	HNRNPDL ZMIZ1	4.23e-03	199	13	2	M7865
Coexpression	GSE17721_0.5H_VS_8H_CPG_BMDC_DN	TFG ILF3	4.23e-03	199	13	2	M4127
Coexpression	GSE19401_NAIVE_VS_IMMUNIZED_MOUSE_PLN_FOLLICULAR_DC_UP	FUS HNRNPA3	4.23e-03	199	13	2	M7656
Coexpression	GSE36888_UNTREATED_VS_IL2_TREATED_TCELL_6H_DN	MEX3B HNRNPA3	4.23e-03	199	13	2	M8741
Coexpression	GSE3982_EOSINOPHIL_VS_BCELL_UP	FUS ZMIZ1	4.23e-03	199	13	2	M5406
Coexpression	GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_10H_UP	EWSR1 HNRNPA3	4.28e-03	200	13	2	M9643
Coexpression	GSE24574_NAIVE_VS_TCONV_CD4_TCELL_DN	FUS HNRNPA3	4.28e-03	200	13	2	M8330
Coexpression	GSE4142_PLASMA_CELL_VS_GC_BCELL_UP	TAF15 AMOTL1	4.28e-03	200	13	2	M6390
Coexpression	GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP	MEX3B HNRNPA3	4.28e-03	200	13	2	M5087
Coexpression	GSE27859_DC_VS_CD11C_INT_F480_HI_MACROPHAGE_UP	HNRNPDL EWSR1	4.28e-03	200	13	2	M8597
Coexpression	GSE22886_NAIVE_TCELL_VS_DC_DN	TFG ZMIZ1	4.28e-03	200	13	2	M4476
Coexpression	GSE5589_IL6_KO_VS_IL10_KO_LPS_STIM_MACROPHAGE_45MIN_UP	HNRNPDL MEX3B	4.28e-03	200	13	2	M6653
Coexpression	GSE14308_TH1_VS_TH17_UP	EWSR1 ZMIZ1	4.28e-03	200	13	2	M3371
Coexpression	GSE22886_NAIVE_CD8_TCELL_VS_DC_DN	TFG ZMIZ1	4.28e-03	200	13	2	M4492
Coexpression	GSE22886_NAIVE_BCELL_VS_DC_DN	TFG ZMIZ1	4.28e-03	200	13	2	M4484
Coexpression	GSE3982_CTRL_VS_LPS_4H_MAC_UP	SS18L1 ZMIZ1	4.28e-03	200	13	2	M5367
Coexpression	GSE2405_0H_VS_24H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP	HNRNPDL HNRNPA3	4.28e-03	200	13	2	M6204
Coexpression	GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_3H_DN	EWSR1 HNRNPA3	4.28e-03	200	13	2	M9950
Coexpression	GSE27786_NKTCELL_VS_MONO_MAC_UP	MEX3B HNRNPA3	4.28e-03	200	13	2	M4870
Coexpression	GSE9006_TYPE_1_DIABETES_AT_DX_VS_1MONTH_POST_DX_PBMC_UP	EWSR1 HNRNPA3	4.28e-03	200	13	2	M5783
Coexpression	GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_UP	TFG EWSR1	4.28e-03	200	13	2	M3832
Coexpression	GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP	MEX3B ARID1B	4.28e-03	200	13	2	M8090
Coexpression	GSE4748_CTRL_VS_LPS_AND_CYANOBACTERIUM_LPSLIKE_STIM_DC_3H_UP	EWSR1 ILF3	4.28e-03	200	13	2	M6484
Coexpression	GSE2770_UNTREATED_VS_ACT_CD4_TCELL_2H_DN	TFG EWSR1	4.28e-03	200	13	2	M6020
Coexpression	GSE44649_NAIVE_VS_ACTIVATED_CD8_TCELL_MIR155_KO_UP	ILF3 HNRNPA3	4.28e-03	200	13	2	M9776
Coexpression	GSE25890_CTRL_VS_IL33_IL7_TREATED_NUOCYTES_DN	HNRNPDL FUS	4.28e-03	200	13	2	M7356
Coexpression	GSE20198_IL12_VS_IL12_IL18_TREATED_ACT_CD4_TCELL_DN	ZMIZ1 HNRNPA3	4.28e-03	200	13	2	M7372
Coexpression	HALLMARK_G2M_CHECKPOINT	EWSR1 ILF3	4.28e-03	200	13	2	M5901
Coexpression	GSE29164_DAY3_VS_DAY7_CD8_TCELL_AND_IL12_TREATED_MELANOMA_UP	MEX3B TAF15	4.28e-03	200	13	2	M8495
Coexpression	GSE17721_12H_VS_24H_POLYIC_BMDC_UP	TFG ILF3	4.28e-03	200	13	2	M4101
Coexpression	GSE5542_IFNG_VS_IFNA_TREATED_EPITHELIAL_CELLS_24H_UP	ILF3 HNRNPA3	4.28e-03	200	13	2	M6544
Coexpression	GSE1925_CTRL_VS_IFNG_PRIMED_MACROPHAGE_24H_IFNG_STIM_DN	HNRNPDL ILF3	4.28e-03	200	13	2	M6309
Coexpression	GSE22196_HEALTHY_VS_OBESE_MOUSE_SKIN_GAMMADELTA_TCELL_DN	FUS HNRNPA3	4.28e-03	200	13	2	M7653
Coexpression	GSE30083_SP1_VS_SP4_THYMOCYTE_UP	HNRNPDL ILF3	4.28e-03	200	13	2	M5028
Coexpression	GSE1448_CTRL_VS_ANTI_VBETA5_DP_THYMOCYTE_DN	FUS ILF3	4.28e-03	200	13	2	M3429
Coexpression	GSE8685_IL2_STARVED_VS_IL15_ACT_IL2_STARVED_CD4_TCELL_DN	ZMIZ1 HNRNPA3	4.28e-03	200	13	2	M327
Coexpression	GSE22432_MULTIPOTENT_PROGENITOR_VS_CDC_DN	FUS HNRNPA3	4.28e-03	200	13	2	M7819
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	EWSR1 TAF15 HNRNPA3	1.75e-04	185	13	3	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K3
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_500	MEX3B ZMIZ1	2.66e-04	40	13	2	gudmap_developingGonad_e16.5_epididymis_500_k5
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#4	TFG EWSR1 TAF15 HNRNPA3	3.57e-04	595	13	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K4
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_500	MEX3B ZMIZ1	4.17e-04	50	13	2	gudmap_developingGonad_e14.5_ epididymis_500_k1
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-vs-F_top274_274	HNRNPDL MEX3B AMOTL1	4.53e-04	256	13	3	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_M-2fold-vs-F_top305_305	MEX3B AMOTL1 FUS	5.07e-04	266	13	3	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_250_M-vs-F-2X
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000	MEX3B FUS ZMIZ1	6.13e-04	284	13	3	gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlas	DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_top-relative-expression-ranked_100	MEX3B FUS	1.04e-03	79	13	2	gudmap_developingGonad_e11.5_ovary + mesonephros_100
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000	MEX3B AMOTL1 FUS ZMIZ1	1.09e-03	801	13	4	gudmap_developingGonad_e14.5_ epididymis_1000
CoexpressionAtlas	DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000	MEX3B EWSR1 FUS ZMIZ1	1.12e-03	806	13	4	gudmap_developingGonad_e12.5_epididymis_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000	ILF3 ZMIZ1	1.37e-03	91	13	2	DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000
CoexpressionAtlas	DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000	TAF15 ILF3 ZMIZ1	1.41e-03	379	13	3	gudmap_developingKidney_e15.5_1000_k3
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	TAF15 ILF3 ZMIZ1	1.48e-03	385	13	3	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_500	MEX3B FUS	1.56e-03	97	13	2	gudmap_developingGonad_e18.5_ovary_500_k3
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000	MEX3B ZMIZ1	1.62e-03	99	13	2	gudmap_developingGonad_e14.5_ epididymis_1000_k1
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	MEX3B FUS ZMIZ1	1.72e-03	406	13	3	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	MEX3B FUS ZMIZ1	1.81e-03	413	13	3	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#5_top-relative-expression-ranked_500	MEX3B FUS	1.96e-03	109	13	2	gudmap_developingGonad_e16.5_ovary_500_k5
CoexpressionAtlas	DevelopingGonad_e11.5_testes and mesonephros_emap-3226_top-relative-expression-ranked_500	MEX3B EWSR1 FUS	2.10e-03	435	13	3	gudmap_developingGonad_e11.5_testes and mesonephros_500
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000	EWSR1 TAF15 ILF3 HNRNPA3	2.30e-03	979	13	4	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000
CoexpressionAtlas	FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1	TFG TAF15 HNRNPA3	2.60e-03	469	13	3	Facebase_RNAseq_e8.5_Floor Plate_2500_K1
ToppCell	droplet-Marrow-BM-1m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HNRNPDL TFG EWSR1 FUS HNRNPA3	1.82e-09	195	13	5	637b06ef3967b03f7165d102d316e8b7161a817d
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL EWSR1 TAF15 FUS HNRNPA3	2.01e-09	199	13	5	5478b78349b5d8d57f30bb650dcbd5fdb84283d6
ToppCell	10x5'v1-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL EWSR1 TAF15 HNRNPA3	2.57e-07	199	13	4	713dfd8552635645db5e0b5721c64e5c9b4aa06c
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL EWSR1 TAF15 HNRNPA3	2.57e-07	199	13	4	ea75804c34989c99aab542e6d72617ed144819b6
ToppCell	COVID-19_Mild\|World / Disease group, lineage and cell class	ARID1B FUS HNRNPA3	2.29e-05	197	13	3	5c33454b10023decd2f5ccda9229b6512659711e
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ARID1B FUS HNRNPA3	2.32e-05	198	13	3	28ef3fc4c17dcb765537b75917f7db78baa522db
ToppCell	PBMC-Mild\|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09)	ARID1B FUS HNRNPA3	2.32e-05	198	13	3	44417089b62056269cac38d3134ff209c05b7007
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL ARID1B FUS	2.36e-05	199	13	3	dd94e42b62af7cbd69c472681d3c758552694ae2
ToppCell	megakaryocytic-CD34+_Megakaryoblast\|megakaryocytic / Lineage and Cell class	HNRNPDL FUS ILF3	2.36e-05	199	13	3	99a65887d3c8a2cde26693dd74404b101bba9d58
ToppCell	Enterocyte_Progenitors\|World / shred on cell type and cluster	HNRNPDL FUS ILF3	2.36e-05	199	13	3	776bcc887927dea9ebd76ec4338ce2225c319c2c
ToppCell	10x5'v1-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL EWSR1 HNRNPA3	2.39e-05	200	13	3	364f09eb9ae4913f5c80a29e943e1c0b2ffd5f93
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL EWSR1 HNRNPA3	2.39e-05	200	13	3	c28d4ca51d2e2a3a22784ee251975f16a55b0297
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B FUS HNRNPA3	2.39e-05	200	13	3	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	COVID-19\|World / Disease, condition lineage and cell class	ARID1B ILF3 HNRNPA3	2.39e-05	200	13	3	7dec470c379cd89f05a0f37c8628b21f136e52f0
ToppCell	COVID-19-COVID-19_Mild\|COVID-19 / Disease, condition lineage and cell class	ARID1B FUS HNRNPA3	2.39e-05	200	13	3	62c25042086f1afd1102e0720e933c2e476468fd
ToppCell	Nasal_Brush-Immune-Dendritic_cells\|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X	HNRNPDL HNRNPA3	2.49e-05	26	13	2	e83bba14028e7684beb3dd0ec5ecf8c88245a202
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2-Sox4\|Hippocampus / BrainAtlas - Mouse McCarroll V32	EWSR1 FUS	6.92e-04	136	13	2	0185486c39700dd2f72d79be6d283494dd8379c9
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5-P5_2\|Hippocampus / BrainAtlas - Mouse McCarroll V32	EWSR1 FUS	6.92e-04	136	13	2	3e13dc0634f3b05e9f9e6c3193f843f62e603b78
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARID1B FUS	8.08e-04	147	13	2	94998bc40f5c08295cfe3bdcbe43f13b1e564b3d
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	ARID1B AMOTL1	9.32e-04	158	13	2	74aa4f75307575ac3b2b1aa9f727753692f88742
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D2\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	ARID1B AMOTL1	9.67e-04	161	13	2	58381131e651744b5141b202f9d6063f55432db5
ToppCell	3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages\|bone_marrow / Manually curated celltypes from each tissue	MEX3B ZMIZ1	1.05e-03	168	13	2	8ade4d098aeecda2d80c1cad1cebe9a063eae948
ToppCell	3'_v3-lymph-node_spleen\|World / Manually curated celltypes from each tissue	ARID1B FUS	1.09e-03	171	13	2	7aae88da5b37c20f10118325a048f08906be994c
ToppCell	remission-HSPC\|remission / disease stage, cell group and cell class	MEX3B AMOTL1	1.09e-03	171	13	2	41b424e58470a2fc25632aea50a37c7c5ea17645
ToppCell	3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-CD8-positive,_alpha-beta_T_cell-CD8_T_cells-CD8_T_cells_L.1.1.0.4\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	HNRNPDL HNRNPA3	1.15e-03	176	13	2	ce85a13e10cf37f5cf38ca8b0bac6701b6d00ffd
ToppCell	3'_v3\|World / Manually curated celltypes from each tissue	ARID1B FUS	1.18e-03	178	13	2	42502f14d9c756df8104900ac6484477b885d3d9
ToppCell	C_00\|World / shred on cell type and cluster	FUS ILF3	1.19e-03	179	13	2	da2dadc3266ffebd4a34ac61bfa05fddcadcde4c
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P5\|Hippocampus / BrainAtlas - Mouse McCarroll V32	EWSR1 FUS	1.21e-03	180	13	2	44988c34861df359a68376500c42a64fbcc4b431
ToppCell	droplet-Liver-nan-3m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEX3B AMOTL1	1.22e-03	181	13	2	fcc94f04dae98b817ec06b282d2e887804d37ae5
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	ARID1B FUS	1.22e-03	181	13	2	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEX3B SS18L1	1.22e-03	181	13	2	ad30c01290fb98adbd0caed301a584761212c977
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEX3B SS18L1	1.22e-03	181	13	2	3a3268a4dff8ffcb79e09f46490e138c96f8d916
ToppCell	facs-Brain_Non-Myeloid-Hippocampus-3m-Epithelial-neuronal_stem_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MEX3B SS18L1	1.22e-03	181	13	2	4e81ec1580e9acb22c32c465eb46f83d1e9e424e
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P5\|Striatum / BrainAtlas - Mouse McCarroll V32	EWSR1 FUS	1.25e-03	183	13	2	f20b0d71f857ac35868fd80531050ad8b6091716
ToppCell	facs-Large_Intestine-Distal-24m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EWSR1 HNRNPA3	1.29e-03	186	13	2	af038994a6c32261f426b0c40c39be4a9099fe43
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B FUS	1.29e-03	186	13	2	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ARID1B FUS	1.29e-03	186	13	2	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	343B-Lymphocytic-CD4_T-cell-Treg_cell_4\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	TFG ZMIZ1	1.29e-03	186	13	2	bca5215d406f1785bf3a420201d5686071fcaca5
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	ARID1B FUS	1.31e-03	188	13	2	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51\|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k)	HNRNPDL FUS	1.33e-03	189	13	2	0e8d1be3c406d1a393e18faccfe89116a8f82bcf
ToppCell	ASK428-Immune-NK_cell\|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq	EWSR1 FUS	1.34e-03	190	13	2	d649f7e17c4227787465dfc02037f791ff85378b
ToppCell	facs-Large_Intestine-Proximal-24m-Epithelial-intestinal_crypt_stem_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EWSR1 HNRNPA3	1.34e-03	190	13	2	933c778bb8ec89621906fe7d484c1d2c6cd28d80
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	FUS ZMIZ1	1.36e-03	191	13	2	40813c397f533c2f4a6359a77757f736b6d9e07d
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage-pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	EWSR1 HNRNPA3	1.40e-03	194	13	2	f64da5f62e29253d60b9546edf734ba5c17daae1
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage-immature_B_cell\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL FUS	1.43e-03	196	13	2	9a6e4eea19348a6e3379d3b872456ab6280cb74f
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Trm_gut_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	HNRNPDL FUS	1.43e-03	196	13	2	528622874692d7d65c905738b078ab53acef5846
ToppCell	Megakaryocytic-erythropoietic-MEP-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	HNRNPDL FUS	1.43e-03	196	13	2	4e97010185fa9392da8f69e7b2a7395bf063f8ff
ToppCell	3'_v3-GI_small-bowel-Lymphocytic_T_CD8\|GI_small-bowel / Manually curated celltypes from each tissue	HNRNPDL FUS	1.43e-03	196	13	2	3f5bf202c5d8c15072255c133793c8ee6e8d932f
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_1_(HAND1+)\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPDL MEX3B	1.43e-03	196	13	2	fd0a2b863dedaf08d18e7f67da18ac7e853991e4
ToppCell	10x5'v1-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	EWSR1 HNRNPA3	1.43e-03	196	13	2	6ba02b806d440eed45bad7616bf3b8be57034427
ToppCell	10x5'v1-week_17-19\|World / cell types per 3 fetal stages;per 3',per 5'	EWSR1 TAF15	1.43e-03	196	13	2	31229affb48521e8be93b6061178fd8cea09ba99
ToppCell	Megakaryocytic-erythropoietic-MEP\|Megakaryocytic-erythropoietic / Lineage, cell class and subclass	HNRNPDL FUS	1.43e-03	196	13	2	f90e7fe3a7b2fff30d01a25cc500876861c2e4f1
ToppCell	COVID-19_Mild-Classical_Monocyte-cMono_4\|Classical_Monocyte / Disease condition and Cell class	FUS HNRNPA3	1.44e-03	197	13	2	e666f6580e9a20b5e550f02125706db17eec8510
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.44e-03	197	13	2	7290f05d0b8465637420119941bcbf2fae44a7e4
ToppCell	facs-Diaphragm-Limb_Muscle-3m\|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FUS HNRNPA3	1.44e-03	197	13	2	b0e2ea81308bce289cb7cbea0e27de1d01afeed2
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.44e-03	197	13	2	78122e1fb80e0ac3084dd4f7c551996330a701df
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HNRNPDL FUS	1.44e-03	197	13	2	cd54e6ad175529327fa0372033016b3b978dd452
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPDL MEX3B	1.44e-03	197	13	2	fc718a254bda4df2d62975d04393492fb75ab305
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.44e-03	197	13	2	106b0f9a0425facc634feb7498c9ba2c55edfbf8
ToppCell	3'-GW_trimst-1-LargeIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPDL MEX3B	1.44e-03	197	13	2	c7b33d64e5cba3a8fc6f2d6aa85ebc83893195de
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPDL FUS	1.44e-03	197	13	2	9af431323da6d099459b7360af40e5df998cffbd
ToppCell	10x5'v1-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.44e-03	197	13	2	31dfd9842410b5c629f39b5130233995dceb0aef
ToppCell	COVID-19-COVID-19_Convalescent-Others-HSPC\|COVID-19_Convalescent / Disease, condition lineage and cell class	MEX3B AMOTL1	1.44e-03	197	13	2	c1033a1a8b8b5c8569130aa9405a6e8e65ef7bd0
ToppCell	10x_3'_v3\|World / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	FUS HNRNPA3	1.46e-03	198	13	2	aabb8e9b162ae4cb26ea860c99decdbb51e379e1
ToppCell	Healthy_donor\|World / disease group, cell group and cell class (v2)	HNRNPDL FUS	1.46e-03	198	13	2	1ed0b50c9754727a05c27b21f3546bf2e37eef7f
ToppCell	COVID-19_Mild\|World / Disease condition and Cell class	EWSR1 FUS	1.46e-03	198	13	2	61ceb2245b6cb58e308b999a61d218c89dbc615e
ToppCell	3'-GW_trimst-1-LargeIntestine\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	HNRNPDL MEX3B	1.46e-03	198	13	2	ea6621a148a96c8ffa1a93a35c9e288545d2637a
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL FUS	1.46e-03	198	13	2	5f465cf5c7493e32d9afe9e9d05757d0a95acc33
ToppCell	10x3'2.3-week_17-19-Lymphocytic_B-B_lineage\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL FUS	1.46e-03	198	13	2	77ce3fe1ab161c0faf8987e73a64ab61294b9255
ToppCell	PBMC_fresh-frozen\|World / Compartment, severity and other cell annotations on 10x 3' data (130k)	HNRNPDL ARID1B	1.46e-03	198	13	2	dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a
ToppCell	390C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HNRNPDL HNRNPA3	1.46e-03	198	13	2	a1c8e5c332336823c47c04e56b6d7bc8f057c9da
ToppCell	356C-Lymphocytic-NK_cells-NK_cell_A\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	HNRNPDL FUS	1.46e-03	198	13	2	ec115c4a5dbc54206c72140aa0c8d6a7c29c5563
ToppCell	lymphoid\|World / Lineage, cell class and subclass	HNRNPDL FUS	1.47e-03	199	13	2	bf599721e7109cf9f361e9381544c291920c28be
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.47e-03	199	13	2	cdee798e3586e4e7a15de598239090a85752ea1e
ToppCell	10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pre_B_progenitor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	EWSR1 HNRNPA3	1.47e-03	199	13	2	be425e9cb90a73289026b1b7cb581e1c02a8985e
ToppCell	Healthy/Control\|World / Disease group and Cell class	HNRNPDL FUS	1.47e-03	199	13	2	2623c42b3e79e401a485879b52e8bbcbc581544d
ToppCell	(08)_Brush+PNEC\|World / shred by cell type by condition	MEX3B ZMIZ1	1.47e-03	199	13	2	f2e33cb569c25fc2732722cac295647e9bd8738f
ToppCell	10x3'2.3-week_12-13-Lymphocytic_B-B_lineage\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.47e-03	199	13	2	fe3b7d540a644dfc6beea171c809b4d1ba4e188f
ToppCell	10x5'v1-week_14-16-Lymphocytic_B-B_lineage-pre_pro_B_progenitor\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.47e-03	199	13	2	8daf945fc93169b0a4fa3ef9f4a87eedd52e314a
ToppCell	Caecum-T_cell-cycling_gd_T\|T_cell / Region, Cell class and subclass	AMOTL1 ZMIZ1	1.47e-03	199	13	2	64d1e495307a91bc012130613126d86e0cf170b0
ToppCell	mild-low-quality_cells\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	ARID1B FUS	1.47e-03	199	13	2	f0b0097df0026496470a80d8cc9375ffd8389b00
ToppCell	Sepsis-Bac-SEP\|Sepsis / Disease, condition lineage and cell class	HNRNPDL FUS	1.48e-03	200	13	2	1f80e6a49c632b3ba0cdac1225c78e5d6d6d78a5
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B-B_lineage\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.48e-03	200	13	2	0fd9a8730b7dc461ddf4586899d363541e72d8ba
ToppCell	severe\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	HNRNPDL HNRNPA3	1.48e-03	200	13	2	accc618d6b960bff30cb531c1226295bfc8650f6
ToppCell	5'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FUS HNRNPA3	1.48e-03	200	13	2	4234bdc70a9941d4bf77148d75bd271e0c114b88
ToppCell	TCGA-Bile_Duct-Primary_Tumor-Cholangiocarcinoma\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	FUS ILF3	1.48e-03	200	13	2	ad2a6da0b1ae7a9212a3c91e5eec4baa7481d8dc
ToppCell	wk_08-11\|World / Celltypes from embryonic and fetal-stage human lung	HNRNPDL ILF3	1.48e-03	200	13	2	aa35c33762880a5e030a7e691c425524f7dbff8a
ToppCell	10x3'2.3-week_14-16-Lymphocytic_B\|week_14-16 / cell types per 3 fetal stages;per 3',per 5'	HNRNPDL HNRNPA3	1.48e-03	200	13	2	19a4213f180ac2d29625d140b602a93a74ab3fdd
ToppCell	(5)_Fibroblasts-(5)_Fibroblast-H\|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4)	HNRNPDL EWSR1	1.48e-03	200	13	2	0ebc54d19873a2b7b6d12b81559cb12abd73b90c
ToppCell	TCGA-Bile_Duct-Primary_Tumor\|TCGA-Bile_Duct / Sample_Type by Project: Shred V9	FUS ILF3	1.48e-03	200	13	2	0350e5ffd36033099b7e32a1fdd790fff99790dc
ToppCell	10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HNRNPDL FUS	1.48e-03	200	13	2	48d79c7a9a2d3c10b41e152baf28fb00a4729e48
Computational	Neighborhood of MYST2	SS18L1 ILF3 ZMIZ1	2.13e-04	172	8	3	GCM_MYST2
Computational	Genes in the cancer module 332.	EWSR1 ILF3	4.72e-04	45	8	2	MODULE_332
Computational	Genes in the cancer module 198.	EWSR1 FUS ILF3	1.12e-03	303	8	3	MODULE_198
Computational	Neighborhood of RBBP6	HNRNPDL FUS	1.14e-03	70	8	2	GNF2_RBBP6
Computational	Genes in the cancer module 14.	EWSR1 ILF3 ZMIZ1	1.80e-03	357	8	3	MODULE_15
Computational	Neighborhood of UBE2N	FUS ILF3	2.09e-03	95	8	2	MORF_UBE2N
Computational	Genes in the cancer module 98.	EWSR1 FUS ILF3	2.37e-03	393	8	3	MODULE_98
Computational	Neighborhood of FBL	FUS ILF3	4.48e-03	140	8	2	MORF_FBL
Drug	EMCs	TFG EWSR1 TAF15 FUS	2.93e-09	34	13	4	CID005091655
Drug	A-skin	EWSR1 TAF15 FUS	7.14e-07	32	13	3	CID000208772
Drug	DAPH2	EWSR1 TAF15 FUS	4.41e-06	58	13	3	CID006711154
Drug	NOR-1	TFG EWSR1 TAF15	7.79e-06	70	13	3	CID006399012
Drug	AC1L1AUZ	EWSR1 FUS HNRNPA3	8.74e-05	157	13	3	CID000001160
Drug	AC1L1B55	TFG EWSR1 FUS HNRNPA3	9.67e-05	454	13	4	CID000001287
Drug	2d41	EWSR1 FUS	1.05e-04	27	13	2	CID009543496
Drug	P-NE	EWSR1 TAF15 FUS	1.09e-04	169	13	3	CID000446755
Drug	2H1H	EWSR1 FUS	1.13e-04	28	13	2	CID011527397
Drug	AC1NRA5C	EWSR1 FUS HNRNPA3	1.19e-04	174	13	3	CID005287709
Drug	Clenbuterol hydrochloride [21898-19-1]; Down 200; 12.8uM; HL60; HG-U133A	HNRNPDL TAF15 ILF3	1.56e-04	191	13	3	1613_DN
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A	TAF15 FUS ILF3	1.59e-04	192	13	3	6573_UP
Drug	Griseofulvin [126-07-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A	HNRNPDL TAF15 FUS	1.64e-04	194	13	3	2293_DN
Drug	Isoxsuprine hydrochloride [579-56-6]; Down 200; 11.8uM; HL60; HG-U133A	TAF15 SS18L1 FUS	1.66e-04	195	13	3	1985_DN
Drug	Isoconazole [27523-40-6]; Down 200; 9.6uM; PC3; HT_HG-U133A	HNRNPDL TAF15 FUS	1.66e-04	195	13	3	5857_DN
Drug	Edrophonium chloride [116-38-1]; Down 200; 19.8uM; PC3; HG-U133A	HNRNPDL TAF15 ILF3	1.69e-04	196	13	3	1936_DN
Drug	Nor 3	EWSR1 FUS	3.63e-04	50	13	2	CID009578441
Drug	12 p	EWSR1 TAF15 FUS	4.51e-04	274	13	3	CID000081248
Drug	butylidenephthalide	FUS HNRNPA3	5.06e-04	59	13	2	ctd:C026105
Drug	RG-2	FUS ILF3	5.58e-04	62	13	2	CID003070537
Drug	3-Otfp	TFG ILF3	6.91e-04	69	13	2	CID000146089
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	EWSR1 TAF15 FUS	5.14e-11	3	12	3	DOID:0060198 (implicated_via_orthology)
Disease	Extraskeletal Myxoid Chondrosarcoma	TFG EWSR1 TAF15	5.14e-10	5	12	3	C1275278
Disease	frontotemporal dementia (implicated_via_orthology)	EWSR1 TAF15 FUS	1.13e-08	12	12	3	DOID:9255 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	EWSR1 TAF15 FUS	2.07e-07	30	12	3	DOID:332 (implicated_via_orthology)
Disease	Amyotrophic Lateral Sclerosis	EWSR1 TAF15 FUS	1.57e-06	58	12	3	C0002736
Disease	autosomal dominant limb-girdle muscular dystrophy type 3 (implicated_via_orthology)	HNRNPDL HNRNPA3	2.27e-06	6	12	2	DOID:0110306 (implicated_via_orthology)
Disease	sitting height ratio	ARID1B ZMIZ1	1.91e-04	51	12	2	EFO_0007118
Disease	breast carcinoma	EWSR1 ARID1B ILF3 ZMIZ1	5.60e-04	1019	12	4	EFO_0000305
Disease	Malignant neoplasm of breast	ARID1B FUS ZMIZ1	8.27e-03	1074	12	3	C0006142
Disease	Myopia	MEX3B ARID1B	1.03e-02	385	12	2	HP_0000545

Protein segments in the cluster

Peptide	Gene	Start	Entry
GQQSSYGQQSSYGQQ	EWSR1	221	Q01844
QQQQQQGAVGHGYYM	AMOTL1	206	Q8IY63
QYGQQGVSGYCQQGQ	ARID1B	666	Q8NFD5
SSYSQQPYNNQGQQQ	TAF15	76	Q92804
GQGQNWNQGFNNYYD	HNRNPDL	341	O14979
YGGQQQSYGQQQSYN	FUS	136	P35637
GSGYQSHQGQQQSYN	ILF3	746	Q12906
GNNNNNGNGYTYTAG	MEX3B	331	Q6ZN04
GNSQYSQQQAGYQQG	SS18L1	306	O75177
GYQQGAAQQQTYSQQ	SS18L1	316	O75177
IYGGSQGNNNNFQTE	WFDC6	106	Q9BQY6
QYQQQAGYGAQQPQA	TFG	246	Q92734
GGNYNDFGNYSGQQQ	HNRNPA3	326	P51991
TNSNDYSSQGNNYQG	ZMIZ1	881	Q9ULJ6